DEVELOPMENT AND CLINICAL TESTING OF THE RUSSIAN VERSION OF THE ACUTE CYSTITIS SYMPTOM SCORE - ACSS


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The Acute Cystitis Symptom Score - ACSS was originally developed in the Uzbek language and has demonstrated high reliability and validity. The study was aimed to develop a Russian version of the ACSS questionnaire and evaluate its psychometric properties. Translation and adaptation of the ACSS questionnaire containing 18 questions, 6 of them - for the typical symptoms of acute cystitis (AC), 4 - for the differential diagnosis; 3 - for the quality of life, and 5 - for the conditions that may affect the choice of treatment, were performed according to the recommendations developed by the Mapi Research Institute. Study involved 83 Russian-speaking women (mean age, 35.6±13.7 years); 38 (45.8%) patients were in the main group (patients with AC), and 45 (54.2%) - in the control group (without AC). Medical examination and appropriate treatment of the respondents were conducted in accordance with approved standards. After completing the course of therapy, 19 (50%) patients of the main group came for the control examination. There was statistically significant difference in the scores obtained in the two groups. Score profiles positively correlated with the results of laboratory tests (rho = 0.26-0.48). Cronbach's alpha for the Russian version of the questionnaire was 0.86 (95% CI, 0.81-0.91), area under the curve in the ROC analysis was 0.96. The results of testing the Russian version correspond to those of the original version. The Russian version of the ACSS questionnaire has high reliability and validity, and can be recommended for clinical research and diagnosis of primary AC, and dynamic monitoring of the effectiveness of the treatment of the Russian-speaking population of patients.

Full Text

Restricted Access

About the authors

J. F Alidjanov

Republican Specialized Center of Urology; Tashkent Medical Academy

Email: dr.alidjanov@gmail.com

U. A Abdufattaev

Tashkent Medical Academy

A. T Makhmudov

Tashkent Medical Academy

D. Kh Mirkhamidov

Tashkent Medical Academy

F. A Khadzhikhanov

Tashkent Medical Academy

A. V Agzamov

Republican Specialized Center of Urology

A. Pilatz

Justus-Liebig Universität

Gießen, Deutschland

K. G Naber

Technische Universität München

München, Deutschland

F. M Wagenlehner

Justus-Liebig Universität

Gießen, Deutschland

F. A Akilov

Republican Specialized Center of Urology; Tashkent Medical Academy

References

  1. Hooton T.M., Stamm W.E. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am. 1991;75(2):339-357.
  2. Foxman B., Barlow R., D'Arcy H., et al. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10(8):509-515.
  3. Foxman B., Gillespie B., Koopman J., et al. Risk factors for second urinary tract infection among college women. Am J Epidemiol. 2000;151(12):1194-1205.
  4. Clayson D., Wild D., Doll H., et al. Validation ofa patient-administered questionnaire to measure the severity and bothersomeness of lower urinary tract symptoms in uncomplicated urinary tract infection (UTI): the UTI Symptom Assessment questionnaire. BJU Int. 2005;96(3):350-359.
  5. Colgan R., Keating K., Dougouih M. Survey of symptom burden in women with uncomplicated urinary tract infections. Clin Drug Investig. 2004;24(1):55-60.
  6. Ellis A.K., Verma S. Quality of life in women with urinary tract infections: is benign disease a misnomer? J Am Board Fam Pract. 2000;13(6):392-397.
  7. Malterud K., Baerheim A. Peeing barbed wire. Symptom experiences in women with lower urinary tract infection. Scand J Prim Health Care. 1999;17(1):49-53.
  8. Brumfitt W., Hamilton-Miller J.M. Prophylactic antibiotics for recurrent urinary tract infections. J Antimicrob Chemother. 1990;25(4):505-512.
  9. Stamm W.E., Hooton T.M. Management of urinary tract infections in adults. N Engl J Med. 1993;329(18):1328-1334.
  10. Bent S., Nallamothu B.K., Simel D.L. et al. Does this woman have an acute uncomplicated urinary tract infection? JAMA. 2002;287(20):2701-2710.
  11. Baerheim A., Digranes A., Jureen R. et al. Generalized symptoms in adult women with acute uncomplicated lower urinary tract infection: an observational study. MedGenMed. 2003;5(3):1.
  12. Gul N., Quadri M. Impact of probability estimation on frequency of urine culture requests in ambulatory settings. J Pak Med Assoc. 2012;62(7):686-690.
  13. Wild D.J., Clayson D.J., Keating K. et al. Validation of a patient-administered questionnaire to measure the activity impairment experienced by women with uncomplicated urinary tract infection: the Activity Impairment Assessment (AIA). Health Qual Life Outcomes. 2005;3:42.
  14. Gopal M., Northington G., Arya L. Clinical symptoms predictive of recurrent urinary tract infections. Am J Obstet Gynecol. 2007;197(1):74e1 -4.
  15. Klimberg I., Shockey G., Ellison H. et al. Time to symptom relief for uncomplicated urinary tract infection treated with extended-release ciprofloxacin: a prospective, open-label, uncontrolled primary care study. Curr Med Res Opin. 2005;21(8):1241-1250.
  16. Knottnerus B.J., Geerlings S.E., Moll van Charante E.P. et al. Women with symptoms of uncomplicated urinary tract infection are often willing to delay antibiotic treatment: a prospective cohort study. BMC Fam Pract. 2013;14:71.
  17. Little P., Merriman R., Turner S. et al. Presentation, pattern, and natural course of severe symptoms, and role of antibiotics and antibiotic resistance among patients presenting with suspected uncomplicated urinary tract infection in primary care: observational study. BMJ. 2010;340:b5633.
  18. Jolleys J.V. The reported prevalence of urinary symptoms in women in one rural general practice. Br J Gen Pract. 1990;40(337):335-337.
  19. Alidjanov J.F., Abdufattaev U.A., Pilatz A. et al. New Self-Reporting Questionnaire to Assess Urinary Tract Infections and Differential Diagnosis: Acute Cystitis Symptom Score (ACSS). Urol Int. 2014.
  20. Acquadro C., Conray K., Giroudet C. et al. Linguistic Validation Manual for Patient-Reported Outcomes (PRO) Instruments. Mapi Research Institute, Lyon, France: Kluwer Academic Publishers. 184. 2004.
  21. Wild D., Eremenco S., Mear I. et al. Multinational trials-recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR Patient-Reported Outcomes Translation and Linguistic Validation Good Research Practices Task Force report. Value Health. 2009;12(4):430-440.
  22. Wild D., Grove A., Martin M. et al. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health. 2005;8(2):94-104.
  23. Sperber A.D. Translation and validation of study instruments for cross-cultural research. Gastroenterology. 2004;126(1 Suppl. 1):S124-128.
  24. Акилов Ф.А., Мухтаров Ш.Т., Гайбуллаев А.А и др. Стандарты диагностики и лечения урологических заболеваний. Ташкент, Узбекистан.: Республиканский специализированный центр урологии, Министерство здравоохранения Республики Узбекистан. 2012.
  25. Kunin C.M., Kunin C.M. Urinary tract infections : detection, prevention, and management. 5th ed. Baltimore: Williams & Wilkins. ix, 1997;419.
  26. Акилов Ф.А., Арустамов Д.Л., Алиджанов Ж.Ф. и др. Разработка узбекской и русской версий вопросника Urinary Tract Infections Symptom Assessment (UTISA). Материалы Съезда урологов Казахстана и II Евразийского андрологического конгресса. 2010. Алматы, Казахстан.
  27. Cronbach L.J. Test reliability; its meaning and determination. Psychometrika.1947;12(1):1-16.
  28. Cronbach L.J. A case study of the split-half reliability coefficient. J Educ Psychol. 1946;37(8):473-480.
  29. Alidjanov J.F., Abdufattaev U.A., Makhsudov S.A. et al. New self-reporting questionnaire to assess urinary tract infections and differential diagnosis: acute cystitis symptom score. Urol Int. 2014;92(2):230-236.
  30. Staquet M., Berzon R., Osoba D. et al. Guidelines for reporting results of quality of life assessments in clinical trials. Qual Life Res. 1996;(5):496-502.
  31. Barry M.J., Fowler F.J., Jr., O'Leary M.P. et al. The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol. 1992;148(5):1549-1557.
  32. Litwin M.S., McNaughton-Collins M., Fowler F.J., Jr. et al. The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162(2):369-375.
  33. Rosen R.C., Riley A., Wagner G. et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830.
  34. Rosen R.C., Cappelleri J.C., Smith M.D. et al. Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res. 1999;11(6):319-326.
  35. Choi E.P., Lam C.L., Chin W.Y. Validation of the International Prostate Symptom Score in Chinese males and females with lower urinary tract symptoms. Health Qual Life Outcomes. 2014;12:1.
  36. Badia X., Garcia-Losa M., Dal-Re R. et al. Validation of a harmonized Spanish version of the IPSS: evidence of equivalence with the original American scale. International Prostate Symptom Score. Urology. 1998;52(4):614-620.
  37. Hammad F.T., Kaya M.A. Development and validation of an Arabic version of the International Prostate Symptom Score. BJU Int. 2010;105(10):1434-1438.
  38. Homma Y., Tsukamoto T., Yasuda K. et al. Linguistic validation of Japanese version of International Prostate Symptom Score and BPH impact index. Nihon Hinyokika Gakkai Zasshi. 2002; 93(6):669-680.
  39. Hochreiter W., Ludwig M., Weidner W. et al. National Institutes of Health (NIH) Chronic Prostatitis Symptom Index. The German version. Urologe A. 2001;40(1):16-17.
  40. Schneider H., Brahler E., Ludwig M. et al. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/ CPPS. Urology. 2004;63(6):1027-1030.
  41. Wiltink J., Hauck E.W., Phadayanon M. et al. Validation of the German version of the International Index of Erectile Function (IIEF) in patients with erectile dysfunction, Peyronie's disease and controls. Int J Impot Res. 2003;15(3):192-197.
  42. Акилов Ф.А., Рахмонов О.М., Мирхамидов Д.Х. и др. Оценка надежности и валидности узбекской и русской версий опросника Международной Шкалы Оценки Простатических Симптомов (IPSS). Экспериментальная и клиническая урология. 2012;4:63-66.
  43. Bleidorn J., Gagyor I., Kochen M.M. et al. Symptomatic treatment (ibuprofen) or antibiotics (ciprofloxacin) for uncomplicated urinary tract infection?-results of a randomized controlled pilot trial. BMC Med. 2010; 8:30.
  44. Ferry S.A., Holm S.E., Stenlund H. et al. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand J Infect Dis. 2004;36(4):296-301.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies